Latest by Sony Salzman
With a TelePrEP program, any patient with a phone or computer would be able to get a prescription for PrEP after a Skype-like consultation with a provider, rather than an in-person visit to a clinic.
What Will It Take to Eliminate HCV in the U.S.? The WHO Global Hepatitis Report Puts It Into the Global Context
According to the WHO's first-ever Global Hepatitis Report, approximately 1.75 million people were infected with hepatitis C in 2015, bringing the total number to 71 million. What can the US and other countries do to bring these numbers down?
To help clinicians and patients navigate the challenges of HIV/HCV coinfection, AETC NCRC released an infographic that addresses the most common barriers preventing HIV-positive people from curing their HCV infection.
A new study published in PLOS Pathogens reveals that a person's viral load prior to starting antiretroviral therapy directly determines his or her level of inflammation later in life.
The power of positive thinking might extend well beyond emotional well-being to include physical benefits such as lower viral load in people with HIV.
A doctor, a pharmacist and a person who juggles multiple conditions reflect on the challenges and offer their best advice.
"We really do focus on what it's like to be born male in the Latino community and the stresses that puts on people, both on men who engage in same sex behavior as well as transgender women," explains Scott D. Rhodes, Ph.D.
On Jan. 4, clinicians across New York State booted up their computers and logged into a virtual classroom, each ready to learn how to improve care for their HIV patients.
Within the next few years, several pipeline hepatitis C drugs are expected to be approved in the U.S., ensuring that even the most difficult-to-treat patients can be cured -- but what challenges remain?
Despite the diversity of new direct-acting antivirals (DAAs), a tiny number of patients are still left behind. Nancy Reau, M.D., presented a summary of soon-to-be-approved drugs that should work for these tough-to-treat patients.